These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34654789)

  • 41. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
    Boehm M; Arnold N; Braithwaite A; Pickworth J; Lu C; Novoyatleva T; Kiely DG; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Lawrie A; Schermuly RT; Kojonazarov B
    BMC Pulm Med; 2018 Mar; 18(1):41. PubMed ID: 29499691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.
    Belletti A; Castro ML; Silvetti S; Greco T; Biondi-Zoccai G; Pasin L; Zangrillo A; Landoni G
    Br J Anaesth; 2015 Nov; 115(5):656-75. PubMed ID: 26475799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Right ventricular injury in young swine: effects of catecholamines on right ventricular function and pulmonary vascular mechanics.
    McGovern JJ; Cheifetz IM; Craig DM; Bengur AR; Quick G; Ungerleider RM; Meliones JN
    Pediatr Res; 2000 Dec; 48(6):763-9. PubMed ID: 11102544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arterial load and right ventricular-vascular coupling in pulmonary hypertension.
    Oakland H; Joseph P; Naeije R; Elassal A; Cullinan M; Heerdt PM; Singh I
    J Appl Physiol (1985); 2021 Jul; 131(1):424-433. PubMed ID: 34043473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Midterm postoperative prognosis of patients with severe left heart valvular disease combined with moderate or severe pulmonary hypertension treated with treprostinil.
    Xu N; Huang ST; Sun KP; Wang ZC; Cao H; Chen Q
    BMC Cardiovasc Disord; 2020 Nov; 20(1):472. PubMed ID: 33143649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What role does the right side of the heart play in circulation?
    Cecconi M; Johnston E; Rhodes A
    Crit Care; 2006; 10 Suppl 3(Suppl 3):S5. PubMed ID: 17164017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RV pressure overload: from hypertrophy to failure.
    van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
    Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
    Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
    J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence.
    Papathanasiou M; Ruhparwar A; Kamler M; Rassaf T; Luedike P
    Pharmacol Ther; 2020 Oct; 214():107619. PubMed ID: 32599009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence, Diagnosis, Perioperative Monitoring and Treatment of Right Ventricular Dysfunction and/or Pulmonary Arterial Hypertension in Cardiac Surgical Patients in Germany-A Postal Survey.
    Heringlake M; Schön J; Pliet T; Haake N; Reinecke A; Habicher M; Sander M; Markewitz A; Reuter DA; Groesdonk HV; Trummer G; Pilarzyk K; von der Brelie M; Bein B; Schirmer U
    Thorac Cardiovasc Surg; 2017 Dec; 65(8):593-600. PubMed ID: 26909559
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
    Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.
    Parikh KS; Doerfler S; Shelburne N; Kennedy K; Whitson J; Dahhan T; Fortin T; Rajagopal S
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):299-304. PubMed ID: 31934912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension.
    Schäfer M; Frank BS; Ivy DD; Abman SH; Stenmark KR; Mitchell MB; Browne LP; Barker AJ; Hunter KS; Kheyfets V; Miller-Reed K; Ing R; Morgan GJ; Truong U
    J Am Heart Assoc; 2021 Apr; 10(8):e020548. PubMed ID: 33821682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment strategies for the right heart in pulmonary hypertension.
    Westerhof BE; Saouti N; van der Laarse WJ; Westerhof N; Vonk Noordegraaf A
    Cardiovasc Res; 2017 Oct; 113(12):1465-1473. PubMed ID: 28957540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.
    Tampakakis E; Shah SJ; Borlaug BA; Leary PJ; Patel HH; Miller WL; Kelemen BW; Houston BA; Kolb TM; Damico R; Mathai SC; Kasper EK; Hassoun PM; Kass DA; Tedford RJ
    Circ Heart Fail; 2018 Apr; 11(4):e004436. PubMed ID: 29643065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment - predictors of procedure success and duration in pulmonary artery hypertension.
    Knight DS; Kotecha T; Martinez-Naharro A; Brown JT; Bertelli M; Fontana M; Muthurangu V; Coghlan JG
    J Cardiovasc Magn Reson; 2019 Sep; 21(1):57. PubMed ID: 31495338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Right ventricular load and contractility in HIV-associated pulmonary hypertension.
    Rajaratnam A; Rehman S; Sharma P; Singh VK; Saul M; Vanderpool RR; Gladwin MT; Simon MA; Morris A
    PLoS One; 2021; 16(2):e0243274. PubMed ID: 33621231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
    Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
    Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.